Sandu Pharma: Trading Window Closed for Q2 FY27 Results

Sandu Pharmaceuticals Ltd has announced the closure of its trading window for the quarter ended September 30, 2026. The window will be closed from October 1, 2026, until 48 hours after the declaration of the financial results for the quarter. This action is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The restriction applies to Directors, KMPs, Promoters, Designated Persons, and their immediate relatives. The date for the Board Meeting to approve the unaudited financial results will be intimated subsequently.